L-Cycloserine
- Generic Name
- L-Cycloserine
- Brand Names
- Seromycin
- Drug Type
- Small Molecule
- Chemical Formula
- C3H6N2O2
- CAS Number
- 339-72-0
- Unique Ingredient Identifier
- AK7DRB7FMO
- Background
Antibiotic substance produced by Streptomyces garyphalus.
- Indication
本品与其他抗结核药联合，用于经一线药物（如吡嗪酰胺、链霉素、异烟肼、利福平和乙胺丁醇）治疗失败的患者。本品还可用于治疗非结核分枝杆菌感染如鸟复合分枝杆菌病的治疗。
- Associated Conditions
- Pulmonary Tuberculosis (TB), Tuberculosis, Extrapulmonary, Grade 1, grade 2, grade 3, grade 4 Urinary Tract Infection
- Associated Therapies
- -
Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)-PLUS
- Conditions
- Interventions
- First Posted Date
- 2021-01-22
- Last Posted Date
- 2024-11-11
- Lead Sponsor
- Huashan Hospital
- Target Recruit Count
- 89
- Registration Number
- NCT04717908
- Locations
- 🇨🇳
The Third People's Hospital of Shenzhen City, Shenzhen, Guangzhou, China
🇨🇳The Central Hospital of Wenzhou City, Wenzhou, Zhejiang, China
🇨🇳Hwa Mei Hosptal,University of Chinese Academy of Sciences(Ningbo No.2 Hospital), Ningbo, Zhejiang, China
D-cycloserine Augmented Treatment for Youth With Tic Disorders
- Conditions
- Interventions
- First Posted Date
- 2020-04-22
- Last Posted Date
- 2023-04-14
- Lead Sponsor
- Johns Hopkins University
- Registration Number
- NCT04357951
- Locations
- 🇺🇸
Johns Hopkins University School of Medicine, Baltimore, Maryland, United States
Multimodal Cue Exposure Therapy for Smoking Cessation
- First Posted Date
- 2019-07-29
- Last Posted Date
- 2021-02-12
- Lead Sponsor
- Boston University Charles River Campus
- Registration Number
- NCT04035603
The Effect of D-cycloserine on Emotional Processing
- Conditions
- Interventions
- First Posted Date
- 2019-05-23
- Last Posted Date
- 2019-05-23
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 40
- Registration Number
- NCT03961464
- Locations
- 🇬🇧
University of Oxford, Oxford, United Kingdom
Adjunctive D-Cycloserine in Major Depressive Disorder
- Conditions
- Interventions
- First Posted Date
- 2019-05-06
- Last Posted Date
- 2022-01-10
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 50
- Registration Number
- NCT03937596
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
AIH for Spinal Cord Repair
- Conditions
- Interventions
- First Posted Date
- 2018-12-19
- Last Posted Date
- 2024-02-15
- Lead Sponsor
- VA Office of Research and Development
- Target Recruit Count
- 90
- Registration Number
- NCT03780829
- Locations
- 🇺🇸
Edward Hines Jr. VA Hospital, Hines, IL, Hines, Illinois, United States
D-cycloserine for the Treatment of Chronic, Refractory Low Back Pain
- First Posted Date
- 2018-05-24
- Last Posted Date
- 2024-07-15
- Lead Sponsor
- Northwestern University
- Target Recruit Count
- 203
- Registration Number
- NCT03535688
- Locations
- 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States
Cycloserine rTMS Plasticity Augmentation in Depression
- Conditions
- Interventions
- First Posted Date
- 2018-04-30
- Last Posted Date
- 2022-01-05
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 12
- Registration Number
- NCT03511599
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
Cycloserine rTMS Plasticity Augmentation
- Conditions
- Interventions
- First Posted Date
- 2018-02-14
- Last Posted Date
- 2018-11-09
- Lead Sponsor
- University of Calgary
- Target Recruit Count
- 12
- Registration Number
- NCT03432689
- Locations
- 🇨🇦
University of Calgary, Calgary, Alberta, Canada
Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD
- Conditions
- Interventions
- First Posted Date
- 2017-07-13
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Boston University Charles River Campus
- Registration Number
- NCT03216356
- Locations
- 🇺🇸
Center for Anxiety and Related Disorders at Boston University, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.